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ABSTRACT
Fertility in mammals is controlled by hypothalamic neurons that
secrete gonadotropin-releasing hormone (GnRH). These neurons
differentiate in the olfactory placodes during embryogenesis and
migrate from the nose to the hypothalamus before birth. Information
regarding this process in humans is sparse. Here, we adapted new
tissue-clearing and whole-mount immunohistochemical techniques
to entire human embryos/fetuses to meticulously study this system
during the first trimester of gestation in the largest series of human
fetuses examined to date. Combining these cutting-edge techniques
with conventional immunohistochemistry, we provide the first
chronological and quantitative analysis of GnRH neuron origins,
differentiation and migration, as well as a 3D atlas of their distribution
in the fetal brain. We reveal not only that the number of GnRH-
immunoreactive neurons in humans is significantly higher than
previously thought, but that GnRH cells migrate into several
extrahypothalamic brain regions in addition to the hypothalamus.
Their presence in these areas raises the possibility that GnRH has
non-reproductive roles, creating new avenues for research on GnRH
functions in cognitive, behavioral and physiological processes.
KEY WORDS: GnRH neurons, Human development, Fertility,
Transparent brain, 3DISCO
INTRODUCTION
Reproduction and fertility in mammals depend on the function of a
small population of cells – the gonadotropin-releasing hormone
(GnRH) neurons. These neurons project to the hypothalamic
median eminence and release GnRH into the pituitary portal blood
circulation for delivery to the anterior pituitary, where it elicits the
secretion of the gonadotropins, luteinizing hormone and follicle-
stimulating hormone (Christian and Moenter, 2010). Failure of the
GnRH system to develop or secrete properly is associated with
clinical syndromes of reduced sexual competence or infertility
(Boehm et al., 2015).
The development of the GnRH and olfactory systems are
intimately entwined (Boehm et al., 2015). Indeed, during
embryonic development GnRH neurons are born in the medial
part of the nasal placode [the presumptive vomeronasal organ
(VNO)] and enter the brain along a migratory route formed by the
central trunk of the terminal (TN; nervus terminalis or cranial nerve
0), vomeronasal (VNN) and olfactory nerves (Schwanzel-Fukuda
and Pfaff, 1989; Vilensky, 2014; Wirsig-Wiechmann and Oka,
2002; Wray et al., 1989). In humans, as in other vertebrates, the
nasal placodes develop as thickenings of the ectoderm on the
ventrolateral sides of the head around the fifth week of gestation
(Muller and O’Rahilly, 2004). However, while the sequence and
coordination of the events governing the differentiation and
migration of GnRH neurons from the nose to the brain have been
studied extensively in several species (Abraham et al., 2009;
Bruneau et al., 2003; Murakami and Arai, 1994; Murakami et al.,
1992; Palevitch et al., 2007; Quanbeck et al., 1997; Ronnekleiv and
Resko, 1990; Schwanzel-Fukuda and Pfaff, 1989; Witkin et al.,
2003; Wray et al., 1989), data in humans are scarce, relying mainly
on scattered embryonic/fetal stages (Kim et al., 1999; Quinton et al.,
1997; Schwanzel-Fukuda et al., 1989, 1996). To better understand
the prenatal development and spatial organization of these neurons
in humans, we combined immunohistochemistry with three-
dimensional (3D) analysis of either reconstructed histological
sections (Luzzati et al., 2011) or of optically cleared whole-mount
embryos/fetuses (Belle et al., 2014; Ertürk et al., 2012; Renier et al.,
2014).
Our results provide the first 3D atlas and cell counts of the
developing GnRH neuronal system in humans during the first
trimester of gestation. The breadth of analysis and level of detail
made possible by these technologies reveal previously
unprecedented target sites and routes of GnRH migration into the
brain.
RESULTS
Formation of the olfactory placode and VNO
Most vertebrates possess two anatomically distinct olfactory
systems: the main olfactory system, which is responsible for the
detection of volatile odorants; and the vomeronasal system, which
mediates the detection of pheromones, primarily non-volatile
signals related to social and reproductive behavior (Dulac and
Torello, 2003).
We first studied the sequential morphogenetic steps leading to
the formation of the human olfactory/vomeronasal systems, the
appearance of the first GnRH-expressing neurons and the initiation
of the GnRH neuronal migratory process. In humans, the olfactoryReceived 9 May 2016; Accepted 5 September 2016
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placodes develop as thickenings of the ectoderm on the
ventrolateral sides of the head around the fifth week of gestation
(Muller and O’Rahilly, 2004). Although there is general
agreement about the existence of a VNO in the human embryo
(Smith and Bhatnagar, 2000), very little information is available
about its development and molecular signature. Here, we first
observed that the placodes invaginate at Carnegie stage (CS) 16
(∼39th day of gestation) to form simple olfactory pits (Fig. 1A,B).
An invagination of the medial olfactory placode gives rise to the
presumptive vomeronasal organ (pVNO) (Fig. 1C,D). We
analyzed the expression of the transcription factors AP-2α
(TFAP2α) and PAX6, the graded expression of which defines
the site of the VNO anlage in rodents (Forni et al., 2011). AP-2α
immunoreactivity could be detected in the epidermis, dorsal and
ventral craniofacial mesenchyme and a few ectodermal cells
within the dorsal and ventral portions of the respiratory epithelium
(Fig. 1A,B). In the nasal region, PAX6 expression was confined to
the medial olfactory epithelium, with a decreasing gradient
towards AP-2α-positive territories (Fig. 1A-C). We were able to
identify symmetrical bean-shaped VNOs, located at the base of the
nasal septum, in all embryos (CS 16-23, n=7; Figs 2 and 3) and
fetuses [gestational weeks (GW) 9-12, n=8] analyzed. By CS 18,
the VNO was closed and almost completely separated from the
nasal cavity (Fig. 2A,B), except caudally, where it maintained
contact with the olfactory epithelium throughout the first trimester
of gestation (Fig. 2C, Fig. 3G).
Whether the VNO retains any proliferative capacity during
embryogenesis in humans was unknown until now. At CS 20,
numerous VNO cells expressed the proliferation marker Ki67
(MKI67) and high levels of the stem cell marker SOX2 (Fig. 2M,N).
By contrast, they were negative for SOX10, a marker of olfactory
ensheathing cells (a type of glial cell with myelinating capacity) and
HuC/D (ELAVL3/4), a marker of immature neurons (Fig. 2M,N).
These observations suggest that the embryonic VNO contains
actively proliferating progenitors that could be the precursors of the
neurons and olfactory ensheathing cells migrating into the
telencephalon from the nasal region.
Ontogenesis of GnRH neurons and the ‘migratory mass’
In rodents, early GnRH neurons migrate together with a
heterogeneous coalescence of placode-derived and neural crest-
derived migratory cells (Forni et al., 2011) and olfactory axons,
collectively called the ‘migratory mass’ (MM) (Miller et al., 2010;
Valverde et al., 1992). This cell migration precedes the targeting of
olfactory sensory axons to the developing olfactory bulb (OB). The
existence of a similar MM in the human embryo has not yet been
described. We thus immunolabeled consecutive sagittal sections of
a CS 16 embryo for GnRH and doublecortin (DCX) (Fig. 1D,E,G),
a marker of immature migratory neurons (Gleeson et al., 1999). We
identified a very small number (50 in total) of immature GnRH-
expressing cells in the nasal mesenchyme, in the medial portion of
the olfactory placode (Fig. 1C-E), adjacent to the basal lamina of the
VNO, showing that the acquisition of cell identity occurs outside the
VNO between GW5 and 6. At this stage, we observed a mixed mass
of immature GnRH neurons expressing DCX (Fig. 1F,G) or βIII-
tubulin (Fig. 1H-J), migrating across the nasal mesenchyme towards
the telencephalon. As in rodents (Miller et al., 2010), GnRH
neurons in humans only represented a small proportion of the MM
(Fig. 1G). Furthermore, these pioneer neurons of the MM expressed
the delta/notch-like EGF repeat containing (DNER) (Fig. 1H-J), a
transmembrane protein specifically localized in the dendrites and
cell bodies of postmitotic neurons.
These data suggest that the morphogenetic programs defining the
development of the olfactory and vomeronasal systems and the
molecular signature of the GnRH migratory route are highly
conserved across evolution (Eiraku et al., 2002; Miller et al., 2010).
Development of the VNN/TN and GnRH neuron migration
Neurons of the VNN and TN, which belong to the accessory
olfactory system, develop simultaneously from the medial part of
the nasal disc, together with GnRH neurons in mammals, including
humans (Muller and O’Rahilly, 2004; Verney et al., 2002). The
VNN and TN travel together across the nasal region (Brown, 1987),
emerging from the vomeronasal epithelium and running medially
from the olfactory epithelium towards the dorsal region of the OB.
Their central entry, however, differs: it has previously been shown
that the VNN reaches the dorsal region of the OB, namely the
developing accessory olfactory bulb (AOB), which is responsible
for coding pheromonal information after birth, whereas the TN
projects both ventrally and dorsally within the forebrain, primarily
to the septal, hypothalamic and limbic areas (Pearson, 1941a,b;
Schwanzel-Fukuda and Silverman, 1980; Wirsig-Wiechmann and
Oka, 2002).
Our immunohistochemical studies of CS 18 embryos revealed a
mixed population of VNN and TN axons emerging from the
VNO, traveling across the nasal septum, crossing the cribriform
plate and projecting into the telencephalon (Fig. 2A). In other
mammals, this axonal scaffold, which serves as a substrate for the
migration of GnRH neurons, expresses transient axonal
glycoprotein 1 (TAG-1; contactin 2) (Yoshida et al., 1995), the
neuron-specific βIII-tubulin (Giacobini et al., 2008), as well as the
neuronal type III intermediate filament protein peripherin (Wray
et al., 1994). These markers are known to be expressed by a subset
of developing olfactory, vomeronasal and terminal axons (Gorham
et al., 1990, 1991) and to highlight the entire GnRH migratory
scaffold from the olfactory pit to the medial septal area (Fueshko
and Wray, 1994). Here, we show that peripherin (Fig. 2D) and
TAG-1 (Fig. 2E) are both expressed along this scaffold of
vomeronasal/terminal axons in CS 19 embryos. At CS 18-20 (∼44
to 49 days of gestation), we observed GnRH-immunopositive
neurons outside the VNO (Fig. 2A). These cells were migrating
across the nasal septum along βIII-tubulin-positive (Fig. 2A) and
TAG-1-positive (Fig. 2F,G) VNN/TN axon bundles, which
emerged from the VNO to project to the developing OB. Of
note, only a few days after their initial appearance, some GnRH
neurons had already entered the telencephalon and could be seen
in the OB, septum and ventral striatum (Fig. 2A). At CS 18,
immunolabeling for the olfactory ensheathing cell marker SOX10
(Barraud et al., 2013; Forni et al., 2011; Miller et al., 2010), βIII-
tubulin and GnRH revealed that olfactory ensheathing cells
enwrapped VNN/TN axons (Fig. 2H). GnRH neurons
intermingled with SOX10-positive cells and immature migratory
neurons (βIII-tubulin positive) in the nasal mesenchyme, on their
way from the VNO to the developing forebrain (Fig. 2I-L).
As mentioned above, in most terrestrial vertebrates the
vomeronasal neurons project to the AOB. The presence of an
accessory olfactory system has also been documented during fetal
life in humans (Bossy, 1980). However, there is no evidence so far
for a neuronal connection between the VNO and the AOB. We
tested this possibility by performing immunohistochemistry for
neuropilin 2 (NRP2) and GnRH on sagittal sections of GW 9 heads
(n=2) containing both the VNO and the AOB (Fig. S1A-D). NRP2,
the receptor for semaphorin 3F, is highly expressed by a subset of
vomeronasal sensory neurons in rodent embryos and along
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vomeronasal axons innervating the AOB (Cariboni et al., 2007;
Cloutier et al., 2002). Moreover, Nrp2−/− mice display a GnRH
migratory defect followed by reduced fertility and hypogonadism,
supporting the direct involvement of neuropilins and their ligands in
the establishment of the GnRH neuroendocrine system (Cariboni
et al., 2007).
We observed strong NRP2 expression in developing neurons of
the VNO at GW 9, as well as along the VNN (Fig. S1B,C). GnRH
neurons migrated in tight association with NRP2-positive fibers
(Fig. S1C). Notably, analysis of the VNO target area revealed
NRP2-expressing fibers in the AOB but not the main OB
(Fig. S1D). These findings provide strong evidence for the
anatomical connection between the human VNO and AOB.
High-resolution 3D imaging of the GnRH migratory pathway
in transparent human embryos
3D imaging of solvent-cleared organs (3DISCO) is a solvent-based
clearing method used to make the brain transparent (Ertürk et al.,
2012; Ertürk and Bradke, 2013). This method has been combined
with an immunolabeling protocol followed by light-sheet laser-
scanning microscopy (LSM) to study neuronal connectivity in
mouse embryos and postnatal brains (Belle et al., 2014; Ertürk et al.,
2012). Here, we adapted this technique for the first time to intact
human embryos and fetuses and gained excellent clearing of the
specimens (Figs 3, 4, Movies 1-3). Whole-mount immunolabeling
of a CS 19 human embryo (∼48th day of gestation) for GnRH and
peripherin followed by 3DISCO optical clearing and LSM provided
Fig. 1. Ontogenesis and molecular
signature of human GnRH neurons at CS 16.
(A,B) Representative AP-2α (green) and PAX6 (red)
immunoreactivity in a sagittal section of a CS16
embryo head. AP-2α and PAX6 are expressed in
opposite gradients in the nasal mesenchyme (NM)
(AP-2α) and in the olfactory placodal epithelium
(PAX6, arrow). (C) DAPI staining showing that in the
olfactory placode an invagination of the medial
olfactory placode (MOP) forms the presumptive
vomeronasal organ (pVNO, arrow). (D) GnRH
neurons (arrows) differentiate outside the pVNO
and express DCX. (E) Early GnRH cells (arrows)
are detected at the border between the NM and the
epithelium of the pVNO. (F) Lateral sagittal section
of a CS 16 embryo head stainedwith DAPI. (G) High
magnification of the boxed area in F. Arrows point to
cell clusters co-expressing GnRH and DCX.
Arrowhead indicates a neurite process of a
DCX-expressing migratory cell. Inset is a
high-magnification view of migratory neurons
expressing both GnRH and DCX. (H-J) The
neuronal migratory mass (MM, arrows) expresses
DCX. GnRH neurons coalescence with the MM.
DNER+ and βIII-tubulin+ cells are detected in the
medial NM forming the MM (H, arrow) and βIII-
tubulin+ cells are present dorsally towards the
developing olfactory bulb (H, arrowhead). βIII-
tubulin+ neurons expressing DNER emerge from
the olfactory epithelium (OE) (I) towards the
coalescence of cells in the NM in a chain-like
fashion. (J) High magnification of a βIII-tubulin+ cell
expressing DNER moving from the OE to the NM.
The dotted line (J) delineates the boundary between
the OE (left side) and the NM (right side). The inset
(J) illustrates a migratory neuron, emerging from the
OE, co-expressing DNER and βIII-tubulin.
FB, forebrain; LV, lateral ventricle; RE, respiratory
epithelium. Scale bars: A,C,F, 200 µm; B, 100 µm;
D,I, 20 µm; E,J, 10 µm; inset in J, 5 µm; G,H, 50 µm.
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high-resolution imaging of immunofluorescent signals (Fig. 3A-E,
Movie 1). At this stage of embryonic development, a bilateral
continuum of GnRH neurons migrated across the nasal region and
started to enter the forebrain, directed towards the neocortex (NCX)
and the septal areas (SEP) (Fig. 3B). The peripherin antibody
allowed us to visualize motor and sensory fibers of the entire
peripheral nervous system in human embryos, including cranial
nerves, olfactory, vomeronasal and terminal fibers (Fig. 3C-E,
Movie 1). The intracranial projections of the TN had already reached
the medial septal area by this embryonic stage. Unexpectedly, a
considerable subset of TN fibers sprouted dorsally and laterally to
telencephalic regions corresponding to the NCX and the developing
hippocampus. We found that GnRH neurons were consistently
juxtaposed to the peripherin-positive VNN/TN while migrating
from the nose into these telencephalic areas (Fig. 3C-E, Movie 1).
We next optically sliced the immunolabeled head of the CS 19
embryo (Fig. 3F) and analyzed these digital coronal slices. The fact
that GnRH neurons appear for the first time in the immediate
vicinity of the VNO and nowhere else further establishes the VNO
as their site of origin (Fig. 3F). These studies also confirm that the
VNO maintains continuity with the olfactory epithelium in more
caudal positions (Fig. 3F). We next performed whole-mount GnRH
immunolabeling of a CS 21 human embryo (∼53rd day of gestation)
and documented the 3D distribution of GnRH neurons (Fig. 4A,B,
Movie 2). At this stage, GnRH cells migrated within the brain in
chain-like structures and proceeded dorsally and laterally towards
Fig. 2. Development of the VNO and
related cellular components. (A-C) GnRH
and βIII-tubulin expression in a coronal
section of a CS 18 human embryo. (A) GnRH
cells migrate along the vomeronasal nerve
(VNN), which expresses βIII-tubulin (lower
boxed region, as enlarged in B, arrows), in
the olfactory bulb (OB), inside the brain at the
level of the septum (white square; arrows in
inset indicate GnRH neurons that reached
the septum). (B) Magnification of the VNO
and OE in A. Arrowheads indicate the VNN.
(C) Caudally, the VNO is fused with the
developing OE. (D) GnRH cells migrate
along peripherin+ axons across the NM.
(E-G) Confocal images for TAG-1+
(E, arrows) and GnRH+ (F) cells in a CS 19
embryo. (G) Higher magnification of the
white box in F. TAG-1 is expressed along the
VNN. (H-L) Triple immunolabeling showing
expression of GnRH, βIII-tubulin and SOX10
in a coronal section of a VNO at CS 18.
GnRH neurons (I) are intermingled in the NM
with migratory neurons (βIII-tubulin+, J)
and ensheathing SOX10+ cells (K,L).
(M,N) Expression of Ki67, HuC/D and
SOX10 (M) or SOX2 (N) inside the VNO at
CS 20. NEP, neuroepithelium; ON, olfactory
nerve; SEP, septum; other abbreviations as
Fig. 1. Scale bars: A, 500 µm; B,C, 50 µm;
D,I-L, 10 µm; E,F, 60 µm; G,H,M,N, 20 µm.
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the septum, OB and cortex (Fig. 4A,B, arrowheads). Moreover,
some GnRH-positive cells formed a loop and started turning
ventrally towards the developing hypothalamus (Fig. 4A,B).
A few days later, at GW 9, many GnRH neurons were still found
in the nasal compartment in close association with TAG-1-
immunoreactive VNN/TN axons. In addition, some GnRH cells
had assumed an unexpected ring-like distribution, forming two
symmetric circles around the developing OB (Fig. 4C,D, Movie 3).
Inside the brain, GnRH neurons were no longer organized in
continuous chains but were rather more widely spaced and scattered
across multiple areas (Fig. 4E,F).
The distribution and number of GnRH neurons in the human
fetal brain
In rodents, GnRH neurons migrate into the forebrain and appear to
detach from the peripherin-positive terminals of VNN/TN fibers
before entering the septal-preoptic area (Yoshida et al., 1995). In
order to determine whether this was also the case in humans,
coronal sections of a CS 23 embryo (∼GW 8) were
immunolabeled for peripherin and GnRH. Peripherin-positive
fibers projected deeper than expected, to the mediobasal
hypothalamus and developing median eminence (Fig. 5A).
GnRH neurons were detectable in these regions, but always in
tight apposition to peripherin-positive fibers right up to their target
sites (Fig. 5A, inset). This suggests a fundamental difference
between rodents and humans in the mode of migration of GnRH
neurons during the last phase of their journey. Alternatively, VNN/
TN axonal terminals might also persist in these areas in rodents,
but no longer express peripherin.
At GW 9, in keeping with the identification of a dorsal/lateral
branch of the TN in CS 19 embryos, GnRH neurons were distributed
along two different migratory streams. The first, a ventral migratory
pathway directed towards the presumptive hypothalamic regions
(Fig. 5B, white arrow), has previously been documented in humans
(Schwanzel-Fukuda et al., 1989, 1996). In addition, we provide
evidence for an unexpected dorsal migratory pathway for GnRH
Fig. 3. Whole-mount immunolabeling and 3DISCO optical clearing of a CS 19 embryo. Representative image of a CS 19 human embryo after 3DISCO
immunolabeling and optical clearing. (A-E) CS19 embryo labeled for GnRH and peripherin. (B-E) Different views of the entire transparent head depicting the
GnRHmigratory neurons (green) and themigratory scaffold (red, peripherin+). Dotted lines define the boundaries between the nose and the brain. Arrows indicate
the VNN/TN. (F) Rostrocaudal optical sections of the nasal region of the same embryo. GnRH neurons emerge from the VNO (arrows) andmigrate along the VNN/
TN. The VNO is separated from the OE rostrally but is fused with the OE caudally. NCX, neocortex; NTG, nervus terminalis ganglion; OP, olfactory placode; TN,
terminal nerve; other abbreviations as previous figures. Scale bars: A, 800 µm; B, 200 µm; C-E, 300 µm; F, 100 µm.
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neurons, directed towards pallial and subpallial telencephalic
regions (Fig. 5B, red arrow).
Here, we counted for the first time the GnRH cells at different
developmental stages between GW 5.5 (CS 16) and GW 12. At CS
16 (the earliest embryonic stagewe had access to; n=1), we observed
50 GnRH neurons, all of which were restricted to the nasal region
(Fig. 5C). Only a few days later [GW 6 (CS 17-18), n=3], the
number of GnRH neurons had expanded to 7951±2000, indicating
that (1) full GnRH neuronal differentiation occurs between 39 and
44 days of gestation and (2) GnRH neurons migrate rapidly
during early embryogenesis (Fig. 5C). On average, ∼10,000
immunoreactive GnRH neurons were detectable at four
developmental stages spanning GW 6 to GW 12. This number is
five times higher than previously estimated (Crowley et al., 2008;
Tobet et al., 2001).
We did not observe any sex difference in the number of
GnRH cells in GW 7-10 fetuses (n=4 males, mean GnRH
cell number=11,123±2815; n=4 females, mean GnRH cell
number=10,565±1693; t-test, P=0.8706). At each stage, we also
quantified the relative distribution of GnRH cell bodies in three
Fig. 4. Whole-mount immunolabeling and 3DISCO clearing of a CS 21 embryo and two GW 9 fetuses. (A,B) Lateral and oblique projections of the whole
head of a CS 21 human embryo immunolabeled for GnRH. Chains of GnRH neurons enter the brain and progress either dorsally (arrows) or ventrally
(arrowheads) toward the developing hypothalamus (HYP). (C,D) Whole-mount GnRH/TAG-1 immunolabeling of a GW 9 fetal nose. (E,F) Dorsal and lateral
projections of a GW 9 head immunolabeled for GnRH. At this stage, GnRH neurons are distributed in several brain areas, including the HYP. CX, cortex; other
abbreviations as previous figures. Scale bars: A,B, 500 µm; C,D, 200 µm; E, 300 µm; F, 400 µm.
3974











areas: the nose/OB, and the ventral and dorsal migratory streams
(Fig. 5D). At CS 16, GnRH immunoreactivity was restricted to the
nose. At CS 17-18,∼60% of the cells were migrating within the nose,
36% had entered the brain along the dorsal migratory stream and 4%
had started to turn ventrally towards the basal forebrain. During
subsequent stages (CS 19 to GW 12, n=11; Fig. 5D,E), the number of
cells in the nose progressively decreased, with a concomitant increase
in cells in the dorsal and ventral migratory pathways. At the latest
time point analyzed (GW 11-12, n=3), only 23% of GnRH neurons
were located in the more rostral regions (nose/OB).
To understand in greater detail the anatomical distribution of
GnRHneurons in human fetal brains, we performed 3D reconstruction
analysis of serial sections at this fetal stage (GW 9, n=2; Fig. 6A,
Movie 4). Our analysis confirmed that GnRH neurons migrated into
the brain along two main migratory pathways, including the newly
identified dorsal pathway. The latter pathway comprised two
components: (1) one medial, reaching the septum/diagonal band
of Broca, indusium griseum/presumptive hippocampus and
rostromedial neocortex; and (2) one lateral, reaching the ventral
striatum, piriform cortex and amygdala (Fig. 6A).
An anatomical atlas of developing human GnRH cells is currently
unavailable. To generate a detailed distribution map of GnRH
neurons in GW 12 fetuses (the latest developmental stage available
for these studies), we immunolabeled serial coronal sections of GW
Fig. 5. Quantification of GnRH neurons during the first trimester of human gestation. (A) Representative coronal section of a GW 9 human fetal
hypothalamus immunolabeled for GnRH (green) and peripherin (red). Peripherin+ fibers project to the basal hypothalamus and developing median eminence.
Inset shows that GnRH neurons migrate to their final hypothalamic target areas in tight association with the peripherin+ fibers. (B) Representative sagittal section
of a CS 23 fetal brain immunolabeled for GnRH. GnRH neurons enter the brain following a dorsal (red arrow) and a ventral (white arrow) migratory pathway. Inset
shows migratory GnRH cells in the dorsal pathway at high magnification. Arrowhead indicates the region depicted in the inset. (C) Quantification of the mean total
GnRH cell number during the first trimester of gestation in humans as a function of the developmental stages. (D) Distribution of GnRH cells expressed as a
percentage of total cells calculated as a function of the developmental stages in three anatomical compartments: nose, dorsal and ventral migratory pathway (mp).
(E) Schematic representation of GnRH migration during the first trimester of gestation in humans. Values are mean±s.e.m. ME, median eminence; III V, third
ventricle; other abbreviations as previous figures. Scale bars: A, 100 µm; inset in A, 20 µm; B, 50 µm; inset in B, 10 µm.
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12 heads and performed a 3D reconstruction of GnRH cell bodies
and fibers (n=2; Fig. S2A,B, Movie 5). This experiment revealed a
surprisingly wide distribution of GnRH cell bodies and fibers in the
hypothalamus (Fig. S2A-D) as well as several extrahypothalamic
areas, including the OB, cerebral cortex, hippocampus, piriform
cortex, amygdala and habenula (Fig. S2A,B,E).
Two forms of GnRH are present in the human brain. Mammalian
GnRH (GNRH1) regulates the reproductive axis (Guillemin, 1967),
whereas the function of GNRH2, originally isolated from the
chicken hypothalamus (cGnRH-2) (Miyamoto et al., 1984), is
largely unknown. In order to verify whether the GnRH-
immunoreactive neurons that we found in the human fetal brain
contain the GNRH1 form, each antiserum was preabsorbed for 24 h
at 4°C with the GNRH1 peptide (GeneCust, Luxemburg) at 5 μg/ml
(Fig. S3A-D). High sequence homology between the GNRH1 and
GNRH2 decapeptides (only three amino acid substitutions) could
allow GNRH1 antibodies to cross-react with GNRH2. Therefore,
we performed fluorescent in situ hybridization (FISH) experiments
using a cRNA probe directed againstGNRH1mRNA, where lack of
significant nucleotide sequence homology would rule out any cross-
reactivity of the GNRH1 probe with GNRH2 mRNA. These
experiments confirmed that the fetal GnRH neurons express
GNRH1 (Fig. S3E,F). This was further confirmed by performing
dual-fluorescent labeling experiments on a GW 10 and a GW 12
fetus (Fig. S4), combining the use of an anti-GnRH (guinea pig)
antibody, which can potentially bind all GnRH forms, with a mouse
polyclonal antibody directed against a human GnRH-associated
peptide 1 (GAP1) sequence (Skrapits et al., 2015), which is specific
Fig. 6. GnRH neuronsmigrate following a dorsal and a ventral migratory pathway in both human and mouse fetuses. (A) Front (left) and perspective (right)
views of a 3D atlas of the distribution of GnRH neuronal cell bodies and fibers in a GW 9 human embryo. Each cell is represented by a sphere (100 µm in diameter)
colored according to its location (legend on the left). Transparent contours of the NM, OB, septum/diagonal band of Broca (SEP/DB) and indusium griseum/
hippocampus (IG/HIP)arealso shown for reference. In the inset, theposition of thesecontours, togetherwith thenasal turbinates (cyan), is shown. (B-G) Lateral (B,C),
frontal (D), caudal (E) anddorsal (F,G) projections of thewholeheadof anE16.5mouseembryo immunolabeled forGnRHandclearedusing3DISCO.GnRHneurons
are found in the NCX, SEP/DB and HYP (arrows in C), around theOB (arrows in D), in the NCX and piriform cortex (PCX; arrows in E and F) and in deep brain areas
corresponding to the fornix and developing hippocampus (arrow inG). AMY, amygdala; vSTR, central striatum; other abbreviations as previous figures. Scale bars: B,
400 µm; C, 200 µm; D, 180 µm; E-G, 600 µm.
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for the GNRH1. These experiments revealed that all GnRH-
immunoreactive neurons that we found in the human fetal brain
contain the GNRH1 form (Fig. S4A-H).
Confirmation of novel human findings in the mouse embryo
In light of the various novel observations made above regarding
GnRH neuronal migration and distribution in humans, we addressed
the possibility that some of these features might have been
previously overlooked in rodents due to the scattered GnRH
population and the limitations of conventional 2D histology. Using
3DISCO technology coupled with LSM, we performed a detailed
topographical analysis of individual GnRH-immunoreactive
neurons scattered over large brain areas of an E16 whole mouse
embryo (Fig. 6B-G, Movie 6). This analysis confirmed the presence
of a dorsal tract of migratory GnRH neurons, comprising
two telencephalic cell populations oriented dorsally and laterally
(Fig. 6B-D, Movie 6), in addition to the well-known ventral
pathway. Our analysis also revealed a small GnRH neuronal
population in pallial and subpallial regions (Fig. 6C,F,G).
Mimicking our observations in human fetuses (Fig. 4C,D), GnRH
neurons in mouse embryos formed a peculiar ring of cells
surrounding the trunk of the OB (Fig. 6D). We further
investigated whether GnRH neurons were still present in the
mouse OB postnatally or if they were lost during development
(Fig. 7, Movie 7). In whole-mount GnRH-immunolabeled adult
mouse brain hemispheres (n=2, 4-month-old males; Fig. 7A-E,
Movie 7), GnRH neurons and fibers were visible in the
hypothalamic regions (Fig. 7B, Movie 7), as expected. Moreover,
we detected robust GnRH immunoreactivity at the caudal end of the
OB (Fig. 7C, Movie 7), at the border with the cortex. These GnRH
neurons maintained their ring-like distribution around the trunk of
the OB (Fig. 7D, Movie 8). Within the OB, GnRH neurons were
abundantly distributed inside the structure specialized in pheromone
detection, the AOB (Fig. 7D,E). In the adult mouse OB (n=2, 5-
month-old females; Fig. 7F,G), GnRH neurons were still detected in
the glomerular layer of the main and accessory OB (Fig. 7F,G) as
well as in the olfactory nerve layer (Fig. 7H).
DISCUSSION
The GnRH system is the master regulator of reproductive function in
vertebrates, and alterations in GnRH signaling and/or neuronal
development impair human reproduction. It is therefore crucial to
fully understand the mechanisms regulating the ontogenesis,
differentiation and prenatal migration of GnRH neurons from the
nose to the brain. Here we have conducted comprehensive
anatomical studies of human embryos/fetuses in order to obtain
better insight into the development of GnRH neurons during the
first trimester of gestation. The unprecedented use of whole-mount
immunolabeling and 3DISCO technology coupled with LSM in
order to carry out high-resolution visualization of markers for
various cell and fiber types in whole embryos/fetuses has led to
several novel observations concerning this system that could not
have been achieved with conventional histological analysis. These
findings open new avenues in the study of human brain connectivity
under physiological and pathological conditions. For instance, this
study has undertaken the first quantitative analysis of GnRH
neurons in human fetuses. We have established that, on average,
∼10,000 GnRH-immunoreactive neurons are present in the human
brain during fetal development. This number is significantly higher
than previously thought. Indeed, using immunohistochemistry,
many laboratories have assessed the number and distribution of
GnRH neurons in the brains of several mammalian species, with
estimates ranging from 800 cells in the entire brain in adult rodents
to 2000 neurons in the hypothalamus of adult primates (Crowley
et al., 2008; King and Anthony, 1984; Latimer et al., 2000;
Silverman et al., 1982; Tobet et al., 2001). It is worth noting that the
number of GnRH neurons in mice is higher during embryonic
development (1000-1200 neurons) and declines at adulthood
(Messina et al., 2011; Parkash et al., 2012). This might not be the
case in humans, where GNRH1 mRNA-expressing cells remain
widespread in hypothalamic as well as extrahypothalamic regions
(Rance et al., 1994). Of note, Rance and colleagues extended the
analysis of the distribution of GnRH cells by in situ hybridization to
several areas of the adult human brain (Rance et al., 1994) and
reported a similar number of neurons to our findings during fetal
development. However, there has been a certain degree of
skepticism until now as to whether the extrahypothalamic
population would eventually also produce a mature GNRH1
peptide. Our data now reinforce that study and suggest that the
entire population of fetal GnRH neurons is likely to survive until
adulthood, with negligible cell loss. Moreover, the similar
anatomical distribution of GnRH cells in human fetuses and in
adult brains suggests that, by the end of the first trimester of
gestation, GnRH cells occupy their final brain location, with ∼2000
neurons located in the hypothalamus and∼8000 neurons distributed
in widespread brain areas that are not involved in the control of the
hypothalamic-pituitary-gonadal axis.
It has previously been shown in other species that GnRH-
expressing neurons migrate into the brain along branches of the
VNN and TN (Schwanzel-Fukuda and Pfaff, 1989; Wray et al.,
1989), both of which emerge from the vomeronasal epithelium
and run medially from the olfactory epithelium towards the dorsal
region of the OB. However, their central entry point differs: the
VNN reaches the AOB, whereas the TN projects ventrally and
dorsally within the forebrain to target septal, hypothalamic and
limbic areas (Pearson, 1941a; Schwanzel-Fukuda and Silverman,
1980; Wirsig-Wiechmann and Oka, 2002; Wray et al., 1989)
involved in controlling innate behaviors and neuroendocrine
responses. Whether GnRH neurons in humans also reach their
target areas using this axonal scaffold was unknown until now.
Using whole-mount immunolabeling and 3DISCO, we found that
GnRH neurons migrate into several hypothalamic and
extrahypothalamic brain regions in tight association with
peripherin-positive VNN/TN fibers. This indicates that the
vomeronasal and terminal systems play important roles in the
ontogenesis and migration of GnRH neurons in humans, similar to
other mammals. This raises the possibility that some genetic forms
of congenital hypogonadotropic hypogonadism in humans,
characterized by GnRH deficiency and the failure of puberty
onset, might be due to defective central projections of the TN,
causing insufficient/aberrant GnRH migration. In agreement with
this hypothesis, previous studies have shown that intracranial
projections of the VNN/TN, which express neuropilin 1 (NRP1),
the receptor for the guidance molecule semaphorin 3A, fail to
enter the brain and instead accumulate at the dorsal surface of the
cribriform plate in mice lacking a functional semaphorin-binding
domain in NRP1 (Nrp1sema/sema mice) (Hanchate et al., 2012) or
semaphorin 3A (Sema3a−/− mice) (Cariboni et al., 2011).
Concordantly, deficient semaphorin 3A signaling appears to
contribute to some human genetic reproductive disorders
characterized by defective GnRH migration, such as Kallmann
syndrome (Hanchate et al., 2012; Young et al., 2012).
Another striking finding is the existence of an evolutionarily
conserved dorsal migratory path for GnRH neurons within the brain.
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A similar observation was made in non-human primates 20 years
ago (Quanbeck et al., 1997), but was not confirmed or extended to
any other species. In the present study we identified GnRH neurons
along the twomigratory streams in both human andmouse embryos,
and both species possessed unexpected GnRH neuronal populations
in the NCX and the developing piriform cortex, which is involved in
olfaction. An additional previously unreported observation in both
species was the presence of a single-cell-thick ring of GnRH
neurons around each OB. The topography of these cells bears
striking resemblance to a group of olfactory glomeruli called the
‘necklace’ glomeruli, which surround the caudal end of the OBs
(Shinoda et al., 1989). The necklace glomeruli have been implicated
in detecting pheromones (Lin et al., 2004; Teicher et al., 1980), and
our study shows that a significant number of GnRH neurons and
fibers are still present during adulthood in the mouse OB and the
AOB. This suggests that there might be some as yet undetermined
connective or functional link between the GnRH neurons in this
structure and neurons involved in olfactory and/or pheromonal
discrimination.
A structural and functional link between GnRH neuronal
ontogenesis and pheromone detection could also come from our
observations concerning the VNO. In humans and other mammals,
odors constitute chemosensory cues in the establishment of early
interactions between mothers and infants (Dulac et al., 2014), and
several studies have identified behavioral responses to pheromonal
compounds (Dulac and Torello, 2003). However, the issue of
whether these responses are mediated by a functional VNO in
humans has been a matter of extensive debate. Previous studies have
demonstrated the existence of a distinguishable VNO in a
substantial proportion of adult humans (Frasnelli et al., 2011).
However, the neuronal connection between the VNO and the AOB
has remained elusive. Here, we show that during human fetal
Fig. 7. Whole-mount immunolabeling and 3DISCO
clearing of adult mouse brain hemispheres.
(A-E) Adult mouse brain hemisphere immunolabeled for
GnRH (4-month-old males, n=2). (A) Lateral, frontal and
ventral views after digital surface contrast masks.
(B,C) Lateral views of the entire transparent hemi-brain
showing GnRH neurons in the preoptic-hypothalamic
regions (B) and in the OB (C, arrows). (D,E) Rostral and
sagittal optical sections of the OB containing GnRH
neurons. (F-H) GnRH immunoreactivity in a
representative coronal section of an adult mouse OB
(5-month-old-females, n=2). (F) Low-magnification
confocal photomicrograph of the OB showing the
distribution of GnRH cells and fibers in the glomerular
layer (Gl) of the main olfactory bulb (MOB) and accessory
olfactory bulb (AOB), and in the olfactory nerve layer (ON).
(G,H) High-magnification photomicrograph of the AOB (G)
and ON (H). CC, corpus callosum; Grl, granular layer;
POA, preoptic area; other abbreviations as previous
figures. Scale bars: A, 1 mm; B, 400 µm; C, 700 µm;
D, 500 µm; E, 300 µm; F, 120 µm; G, 30 µm; H, 20 µm;
inset in H, 10 µm.
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development the VNO and the AOB are indeed anatomically
connected, since NRP2-immunoreactive vomeronasal fibers project
to the dorsal OB, as reported in rodents (Cloutier et al., 2002). The
VNO also contains strongly Ki67-positive and SOX2-positive
putative neurogenic precursors, in agreement with the increase in
volume of the human fetal VNO epithelium with age and its
persistence at least until birth (Bhatnagar and Smith, 2001; Smith
and Bhatnagar, 2000).
Finally, the computer-assisted 3D reconstruction of tissue
sections immunolabeled for GnRH has allowed the generation of
the first 3D atlas of GnRH cell bodies and fibers from GW 9 and
GW 12 human fetuses. These mapping experiments have revealed
the wide distribution of GnRH cells and terminals in several
extrahypothalamic regions. These observations raise the intriguing
possibility that GnRH signals to GnRH receptor-expressing
neuronal populations dispersed in several brain regions (Granger
et al., 2004; Wilson et al., 2006) to modulate as yet unexplored non-
reproductive functions, such as the recently proposed regulation of
systemic aging (Zhang et al., 2013). Notably, in addition to the
extensive GnRH fiber distribution in those areas, GnRH is also
present in the cerebrospinal fluid at concentrations proportional to
those detected in the portal blood vessels (Van Vugt et al., 1985)
and might thus represent an additional source of GnRH that could
potentially signal to multiple brain regions.
This study will pave the way for new discoveries concerning the
role of GnRH expression and release in human reproductive
physiology, olfactory behavior and cognitive processes.
MATERIALS AND METHODS
Tissue collection and processing
The human gestational period spans the embryonic (first 8 weeks) and fetal
stages of development. The 23 Carnegie stages cover mostly the embryonic
period (∼60 days) and provide a standardized system to characterize
developmental age based on the internal and external morphology of
the human embryo. The ages of the embryos were estimated based on the
following criteria: (1) the attending physicians’ information about
the ‘menstrual weeks’ age of the embryos, generally 2 weeks greater than
the ‘postovulatory age’; (2) external morphology of the embryo; (3)
embryonic (crown-rump) length. The last two criteria were evaluated using
Bayer and Altman’s human brain atlas during the late first trimester (Bayer
and Altman, 2006) and Bossy’s study on the development of olfactory
structures in human embryos (Bossy, 1980).
Embryos and fetuses were fixed by immersion in 4% paraformaldehyde
(PFA) at 4°C overnight or for 2-5 days depending on sample size. The
tissues were cryoprotected in 30% sucrose/PBS at 4°C overnight, embedded
in Tissue-Tek OCT compound (Sakura Finetek), frozen in dry ice and stored
at −80°C until sectioning. Frozen samples were cut serially at 20 µm using a
Leica CM 3050S cryostat (Leica Biosystems). For whole-mount staining
and 3DISCO clearing, samples were washed in ice-cold PBS and fixed by
immersion in 4% PFA at 4°C for 24 h for GW6-8 embryos, 3 days for 9 GW
fetuses, and 5 days for GW 10-12 fetuses. After fixation, samples were
stored at 4°C in 0.1 M PBS pH 7.4 containing 0.01% sodium azide until use.
The number of embryos/fetuses analyzed, the crown-rump length of these
specimens and the type of processing are listed in the Table S1.
Immunolabeling
Human tissueswere cryosectionedat 20 μmthickness. Immunohistochemistry
for GnRH was performed as previously reported (Hanchate et al., 2012). For
immunolabeling ofmouse tissues (genotyped and tissue prepared as described
in the supplementary Materials and Methods), two antibodies previously
characterized on mouse sections were used: rabbit anti-GnRH (1:3000), a gift
from Prof. G. Tramu (Centre Nationale de la Recherche Scientifique, URA
339, Université Bordeaux I, Talence, France) (Beauvillain and Tramu, 1980);
and rabbit anti-GnRH (LR5; 1:1000), a gift from Dr R. Benoit (Montreal
General Hospital, Quebec, Canada). Human samples were immunolabeled
using a guinea-pig anti-GnRH (EH#1018; 1:10,000), produced by Dr Erik
Hrabovszky (Laboratory of Endocrine Neurobiology, Institute of
Experimental Medicine of the Hungarian Academy of Sciences, Budapest,
Hungary) and previously characterized in post-mortem human hypothalami
(Hrabovszky et al., 2011). The mouse antibody directed against the human
GnRH-associated peptide 1 (GAP1) was characterized on adult human
hypothalami by Skrapits et al. (2015). All primary and secondary antibodies
used are listed in Tables S2 and S3.
Incubation in a cocktail of primary antibodies (single, double or triple
labeled) diluted in PBS containing 5%normal donkey serum (D9663, Sigma)
and 0.3% Triton X-100 (Sigma) for 48 h at 4°Cwas followed by a cocktail of
fluorochrome-conjugated secondary antibodies (all raised in donkey; see
Table S3 for details) diluted to 1:500 in PBS for 1-2 h at room temperature.
The number and the distribution of GnRH neurons in fetal brains were
analyzed as indicated in the supplementary Materials and Methods.
In situ hybridization
In situ hybridization on sections of CS19 embryos was carried out using a
digoxigenin-labeled GNRH1 cRNA as described in the supplementary
Materials and Methods.
Image analysis
For 3D reconstruction, a 9 GWand a 12 GW fetus were serially sectioned in
the sagittal plane (20 µm thick), immunolabeled with a GnRH antibody
(EH#1018) and counterstained with Hoechst 33342 (1:10,000; Thermo
Fisher Scientific, #H3570). A subset of these sections, representing an entire
hemisphere of the head, were manually traced with Neurolucida 7.0 (MBF
Bioscience) and aligned using Reconstruct software (Fiala, 2005) version
1.1. The nasal region of the GW 9 fetus was sampled using a greater number
of sections (mean distance between sections of 140 µm) than the caudal part
of the brain (mean distance between sections of 430 µm). For the GW 12
fetus, all sections were spaced 480 µm apart. 3Dmodels were rendered using
Blender 2.7 (www.blender.org).
Optical clearing for human fetuses
The 3DISCO optical clearing procedure has been described previously
(Belle et al., 2014; Ertürk et al., 2012) and was employed here for human
embryos aged 7-8 GW. Pre-methanol treatment was performed to clear the
samples of blood clots, as described in the iDISCO protocol (Renier et al.,
2014) on 9 GW or older samples, and in adult mouse brains.
Imaging
3D imaging was performed as previously described (Belle et al., 2014). An
ultramicroscope (LaVision BioTec) using InspectorPro software (LaVision
BioTec) was used for imaging. The step size between successive images was
fixed at 2 μm.
3D imaging and image processing
Images, 3D volumes and movies were generated using Imaris ×64 software
(version 7.6.1, Bitplane). Stack images were first converted to Imaris files
(.ims) using ImarisFileConverter and 3D reconstruction was performed
using ‘volume rendering’. Optical slices of samples were obtained using the
‘orthoslicer’ tool. The surface of the samples was created using the ‘surface’
tool by creating a mask around each volume. 3D pictures and movies were
generated using the ‘snapshot’ and ‘animation’ tools.
Ethics
Non-pathological human embryos/fetuses were obtained from voluntarily
terminated pregnancies with the parent’s written informed consent
(Gynecology Department, Jeanne de Flandre Hospital, Lille, France).
Tissues were made available in accordance with French bylaws (Good
Practice Concerning the Conservation, Transformation and Transportation
of Human Tissue to be Used Therapeutically, published on December 29,
1998). Permission to use non-pathological human fetal tissues was obtained
from the French Agency for Biomedical Research (Agence de la
Biomédecine, Saint-Denis la Plaine, France, protocol no. PFS16-002).
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Animal studies were approved by the Institutional Ethics Committee for
the Care and Use of Experimental Animals of the University of Lille 2
(France). All experiments were performed in accordance with the guidelines
for animal use specified by the European Union Council Directive of
September 22, 2010 (2010/63/EU).
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